Midbrain dopaminergic neurons are protected from radical induced damage by GDF-5 application

Journal of Neural Transmission

Volumn 106, Issue 2, 1999, Pages 139-144

  Lingor, P ^a   Unsicker, K ^a   Krieglstein, K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Dopaminergic neurons; Fe2+; Neurotrophic factors; NO; Parkinson's disease (PD)

Indexed keywords

NITROPRUSSIDE SODIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL PROTECTION; DOPAMINERGIC NERVE CELL; EMBRYO; MESENCEPHALON; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEINS; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FERROUS COMPOUNDS; FREE RADICALS; GROWTH SUBSTANCES; LETHAL DOSE 50; MESENCEPHALON; NEURONS; NITRIC OXIDE DONORS; NITROPRUSSIDE; PARKINSON DISEASE; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

EID: 0032983894     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050146     Document Type: Article

References (14)

1. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW (1993) Cytotoxicity of microglia. Glia 7: 111-118
2. Clarkson ED, Zawada WM, Freed CR (1995) GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport 7: 145-149
3. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occuring in brain in Parkinson's disease. J Neurochem 52: 1830-1836
4. Farkas LM, Scheuermann S, Pohl J, Unsicker K, Krieglstein K (1997) Characterization of growth/differentiation factor 5 (GDF-5) as a neurotrophic factor for cultured neurons from chicken dorsal root ganglia. Neurosci Lett 236(2): 120-122
5. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminium increase in the substantial nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56: 446-451
6. Hotten GC, Matsumoto T, Kimura M, Bechtold RR, Kron R, Ohara T, Tanaka H, Satoh Y, Okazaki M, Shirai T, Pan H, Kawai S, Pohl JS, Kudo A (1996) Recombinant human growth/differentiation factor-5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13(1-2): 65-74
7. Kienzl E, Puchinger L, Jellinger K, Linert W, Stachelberger H, Jameson RF (1995) The role of transition metals in the pathogenesis of Parkinson's disease. J Neurol Sci 134 [Suppl]: 69-78
8. + toxicity. EMBO J 14: 736-742
9. Krieglstein K, Suter-Crazzolara C, Hotten G, Pohl J, Unsicker K (1995b) Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons. J Neurosci Res 42(5): 724-732
10. Ruberg M, France-Lanord V, Brugg B, Lambeng N, Michel PP, Hunot S, Damier P, Faucheux B, Hirsch E, Agid Y (1997) Neuronal death due to apoptosis in Parkinson's disease. Rev Neurol 153: 499-508
11. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56: 978-982
12. Storm EE, Kingsley DM (1996) Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122(12): 3969-3979
13. Sullivan AM. Opacka-Juffry J, Hotten G, Pohl J, Blunt SB (1997) Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease. Neurosci Lett 233(2-3): 73-76
14. Yamashita H, Shimizu A, Kato M, Nishitoh H, Ichijo H, Hanyu A, Morita I, Kimura M, Makishima F, Miyazono K (1997) Growth/differentiation factor-5 induces angiogenesis in vivo. Exp Cell Res 235(1): 218-226